AEON Biopharma, Inc.
AEON
$0.75
-$0.07-7.98%
AMEX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 5.93M | 8.44M | 10.45M | 13.00K | 537.00K |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.49M | 1.82M | 1.88M | 1.58M | 1.83M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 7.41M | 10.26M | 12.32M | 1.59M | 2.37M |
|
|
|||||
| Total Current Assets | 7.41M | 10.26M | 12.32M | 1.59M | 2.37M |
| Net Property, Plant & Equipment | 1.29M | 1.37M | 1.45M | 1.52M | 1.60M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 29.00K | 29.00K | 29.00K | 29.00K | 29.00K |
| Total Assets | 8.73M | 11.66M | 13.80M | 3.14M | 4.00M |
|
|
|||||
| Total Accounts Payable | 2.53M | 3.91M | 2.44M | 5.91M | 4.63M |
| Total Accrued Expenses | 5.46M | 4.98M | 6.01M | 8.12M | 5.97M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 247.00K | 242.00K | 197.00K | 121.00K | 128.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 8.23M | 9.13M | 8.64M | 14.15M | 10.73M |
|
|
|||||
| Total Current Liabilities | 8.23M | 9.13M | 8.64M | 14.15M | 10.73M |
| Long-Term Debt | 17.05M | 15.17M | 13.32M | 11.69M | 15.17M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 957.00K | 1.02M | 1.08M | 1.15M | 1.20M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 2.37M | 2.19M | 2.08M | 4.73M | 8.99M |
| Total Liabilities | 28.61M | 27.51M | 25.12M | 31.71M | 36.09M |
|
|
|||||
| Common Stock & APIC | 413.81M | 413.29M | 411.18M | 403.03M | 401.59M |
| Retained Earnings | -433.68M | -429.14M | -422.50M | -431.60M | -433.68M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -19.87M | -15.85M | -11.32M | -28.57M | -32.09M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -19.87M | -15.85M | -11.32M | -28.57M | -32.09M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -19.87M | -15.85M | -11.32M | -28.57M | -32.09M |
|
|
|||||